The Implementation of Nongynecologic Reporting Systems in Cytopathology Laboratories Is Highly Variable: Analysis of Data From a 2020 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology

Arch Pathol Lab Med. 2024 May 1;148(5):531-537. doi: 10.5858/arpa.2023-0010-CP.

Abstract

Context: In recent years, several reporting systems have been developed by national and international cytopathology organizations to standardize the evaluation of specific cytopathology specimen types.

Objective: To assess the current implementation rates, implementation methods, and barriers to implementation of commonly used nongynecologic reporting systems in cytopathology laboratories.

Design: Data were analyzed from a survey developed by the College of American Pathologists Cytopathology Committee and distributed to participants in the College of American Pathologists Nongynecologic Cytopathology Education Program mailing.

Results: Nongynecologic reporting systems with the highest rate of adoption were the Bethesda System for Reporting Thyroid Cytopathology, 2nd edition (74.1%; 552 of 745); the Paris System for Reporting Urinary Cytology (53.9%; 397 of 736); and the Milan System for Reporting Salivary Gland Cytopathology (29.1%; 200 of 688). The most common reason given for not adopting a reporting system was satisfaction with a laboratory's current system. Implementation varied among laboratories with regard to which stakeholders were involved in deciding to implement a system and the amount of education provided during the implementation process.

Conclusions: The implementation of nongynecologic reporting systems in cytopathology laboratories was highly variable.

MeSH terms

  • Cytodiagnosis* / methods
  • Cytodiagnosis* / standards
  • Cytology
  • Humans
  • Laboratories / standards
  • Laboratories, Clinical
  • Pathologists
  • Pathology, Clinical* / standards
  • Societies, Medical
  • Surveys and Questionnaires
  • United States